The U.S. medical tubing market size was exhibited at USD 3.85 billion in 2023 and is projected to hit around USD 7.65 billion by 2033, growing at a CAGR of 7.11% during the forecast period 2024 to 2033.
Report Coverage | Details |
Market Size in 2024 | USD 4.12 Billion |
Market Size by 2033 | USD 7.65 Billion |
Growth Rate From 2024 to 2033 | CAGR of 7.11% |
Base Year | 2023 |
Forecast Period | 2024-2033 |
Segments Covered | Product and Application |
Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
Country scope | U.S. |
Key Companies Profiled | Hitachi Cable America Inc,; NewAge Industries Inc.; Spectrum Plastics Group; Bentec Medical; Kent Elastomer Products; The Hygenic Company, LLC; Nordson Corporation |
The market is primarily driven by the rising geriatric population and hospitalizations in the U.S. Medical tubes are required to have superior physical properties such as opacity, versatility, and static resistance. Clear tubing is essential for fluid delivery applications as it enables easy tracking of fluid movement and helps eliminate the possibility of potential air bubbles. Plastic is a key raw material used in the manufacturing of medical tubes, such as conduits for collecting biopsy samples, stent holders, and vascular catheters.
Recent technological advancements have optimized the manufacturing processes, thus driving the market growth. Braided tubing, tapered tubing, and paratubing are manufactured using cutting-edge extrusion technologies to eliminate the assembling of two or more tubes. This fosters cost reduction as it eliminates any secondary steps of joining tubes. Latest advancements in extrusion technologies offer plastic tubes with an integration of desired properties, including high tensile strength, flexibility, lightweight, and non-ferrous properties.
Medical devices in the U.S. are highly regulated by the Food and Drug Administration (FDA) Center Devices and Radiological Health (CDRH) to ensure the safety and effectiveness of the devices. Medical devices are classified into Class I, II, and III, with Class III being associated with higher-risk regulations. The U.S. FDA regulates Good Manufacturing Practices (GMP) polyurethane tubes used to administer drugs or medicines. Similar to the FDA, the United States Department of Agriculture (USDA) ensures that the polyurethane tube does not contaminate the food or liquids given to patients. It also regulates the environmental sustainability compliance of medical tubes.
The bulk disposable segment accounted for the largest market share of 36.75% in 2023. Bulk disposable devices comprise urological products, surgical instruments, syringes, and needles, among others. The growing concerns about containing the spread of communicable diseases are driving segment growth. Furthermore, the prevalence of arthritis, cancer, and cardiovascular diseases has fuelled the adoption of extensive surgical treatment instruments, including trocars and inflators. Polyvinyl chloride (PVC) and silicone are among the most commonly used polymers in disposable medical tubing. They are long-lasting, durable, versatile, and flexible.
Drug delivery systems are expected to expand at the fastest CAGR during the forecast period due to the increasing demand for targeted and controlled drug delivery in patients. Various types of drug delivery systems, such as injectable drug delivery systems, respiratory drug delivery systems, and connected drug delivery systems, use medical tubes to deliver the drug to the target location. The emphasis on improving the efficacy of the drug delivery rate is propelling the demand for medical tubes in the drug delivery systems application segment.
Silicone tubing accounted for the largest revenue share of 26.0% in 2023, owing to its high demand in medical applications. It is non-toxic to living tissues, and patients have no allergenic response. Silicon tubing provides gasketing, sealing, and safe fluid transfer properties, which fosters segment growth. High-grade silicon tubing used in medical devices is manufactured using a continuous vulcanization and extrusion process. Moreover, the material has applications in medical drains, implants, feeding tubes, catheters, and other products where biocompatibility is a key requirement.
Fluoropolymers are projected to grow at the fastest CAGR from 2024 to 2033. It is a preferred material in manufacturing next-generation medical devices, including catheters, sutures, syringes, and biocontainment vessels. Fluoropolymers are inert, non-toxic, sterile, inert, and bio-compatible, making them an ideal choice for medical tubing.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the U.S. medical tubing market
Product
Application
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
Chapter 2. Executive Summary
2.1. Market Insights
2.2. Segment Outlook
2.3. Competitive Landscape Snapshot
Chapter 3. U.S. Medical Tubing Market: Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Market Penetration & Growth Prospects Mapping
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Raw Material Trends
3.4. Regulatory Framework
3.5. Market Dynamics
3.5.1. Market Driver Analysis
3.5.2. Market Restraint Analysis
3.5.3. Industry Challenges
3.5.4. Industry Opportunities
3.6. U.S. Medical Tubing Market- Business Environment Analysis
3.6.1. Industry Analysis- Porter’s Five Force Analysis
3.6.2. Industry Analysis- Macroeconomic Factors Analysis
Chapter 4. U.S. Medical Tubing Market: Product Estimates & Trend Analysis
4.1. Product Movement Analysis & Market Share, 2024 & 2033
4.2. U.S. Medical Tubing Market Estimates & Forecast, By Product, 2021 to 2033
4.3. Silicone
4.3.1. Market Estimates and Forecasts, 2021 - 2033
4.4. Polyolefins
4.4.1. Market Estimates and Forecasts, 2021 - 2033
4.5. Polyimide
4.5.1. Market Estimates and Forecasts, 2021 - 2033
4.6. Polyvinyl Chloride
4.6.1. Market Estimates and Forecasts, 2021 - 2033
4.7. Polycarbonates
4.7.1. Market Estimates and Forecasts, 2021 - 2033
4.8. Fluoropolymers
4.8.1. Market Estimates and Forecasts, 2021 - 2033
4.8.2. Polytetrafluoroethylene (PTFE)
4.8.2.1. Market Estimates and Forecasts, 2021 - 2033
4.8.3. Fluorinated ethylene propylene (FEP)
4.8.3.1. Market Estimates and Forecasts, 2021 - 2033
4.9. Others
4.9.1. Market Estimates and Forecasts, 2021 - 2033
Chapter 5. U.S. Medical Tubing Market: Application Estimates & Trend Analysis
5.1. Application Movement Analysis & Market Share, 2024 & 2033
5.2. U.S. Medical Tubing Market Estimates & Forecast, By Application, 2021 to 2033
5.3. Bulk disposable tubing
5.3.1. Market Estimates and Forecasts, 2021 - 2033
5.3.1.1. Silicone
5.3.1.1.1. Market Estimates and Forecasts, 2021 - 2033
5.3.1.2. Polyolefins
5.3.1.2.1. Market Estimates and Forecasts, 2021 - 2033
5.3.1.3. Polyimide
5.3.1.3.1. Market Estimates and Forecasts, 2021 - 2033
5.3.1.4. Polyvinyl Chloride
5.3.1.4.1. Market Estimates and Forecasts, 2021 - 2033
5.3.1.5. Polycarbonates
5.3.1.5.1. Market Estimates and Forecasts, 2021 - 2033
5.3.1.6. Fluoropolymers
5.3.1.6.1. Market Estimates and Forecasts, 2021 - 2033
5.3.1.7. Polytetrafluoroethylene (PTFE)
5.3.1.7.1. Market Estimates and Forecasts, 2021 - 2033
5.3.1.8. Fluorinated ethylene propylene (FEP)
5.3.1.8.1. Market Estimates and Forecasts, 2021 - 2033
5.3.1.9. Others
5.3.1.9.1. Market Estimates and Forecasts, 2021 - 2033
5.4. Drug delivery systems
5.4.1. Market Estimates and Forecasts, 2021 - 2033
5.4.1.1. Silicone
5.4.1.1.1. Market Estimates and Forecasts, 2021 - 2033
5.4.1.2. Polyolefins
5.4.1.2.1. Market Estimates and Forecasts, 2021 - 2033
5.4.1.3. Polyimide
5.4.1.3.1. Market Estimates and Forecasts, 2021 - 2033
5.4.1.4. Polyvinyl Chloride
5.4.1.4.1. Market Estimates and Forecasts, 2021 - 2033
5.4.1.5. Polycarbonates
5.4.1.5.1. Market Estimates and Forecasts, 2021 - 2033
5.4.1.6. Fluoropolymers
5.4.1.6.1. Market Estimates and Forecasts, 2021 - 2033
5.4.1.7. Polytetrafluoroethylene (PTFE)
5.4.1.7.1. Market Estimates and Forecasts, 2021 - 2033
5.4.1.8. Fluorinated ethylene propylene (FEP)
5.4.1.8.1. Market Estimates and Forecasts, 2021 - 2033
5.4.1.9. Others
5.4.1.9.1. Market Estimates and Forecasts, 2021 - 2033
5.5. Catheters
5.5.1. Market Estimates and Forecasts, 2021 - 2033
5.5.1.1. Silicone
5.5.1.1.1. Market Estimates and Forecasts, 2021 - 2033
5.5.1.2. Polyolefins
5.5.1.2.1. Market Estimates and Forecasts, 2021 - 2033
5.5.1.3. Polyimide
5.5.1.3.1. Market Estimates and Forecasts, 2021 - 2033
5.5.1.4. Polyvinyl Chloride
5.5.1.4.1. Market Estimates and Forecasts, 2021 - 2033
5.5.1.5. Polycarbonates
5.5.1.5.1. Market Estimates and Forecasts, 2021 - 2033
5.5.1.6. Fluoropolymers
5.5.1.6.1. Market Estimates and Forecasts, 2021 - 2033
5.5.1.7. Polytetrafluoroethylene (PTFE)
5.5.1.7.1. Market Estimates and Forecasts, 2021 - 2033
5.5.1.8. Fluorinated ethylene propylene (FEP)
5.5.1.8.1. Market Estimates and Forecasts, 2021 - 2033
5.5.1.9. Others
5.5.1.9.1. Market Estimates and Forecasts, 2021 - 2033
5.6. Biopharmaceutical laboratory equipment
5.6.1. Market Estimates and Forecasts, 2021 - 2033
5.6.1.1. Silicone
5.6.1.1.1. Market Estimates and Forecasts, 2021 - 2033
5.6.1.2. Polyolefins
5.6.1.2.1. Market Estimates and Forecasts, 2021 - 2033
5.6.1.3. Polyimide
5.6.1.3.1. Market Estimates and Forecasts, 2021 - 2033
5.6.1.4. Polyvinyl Chloride
5.6.1.4.1. Market Estimates and Forecasts, 2021 - 2033
5.6.1.5. Polycarbonates
5.6.1.5.1. Market Estimates and Forecasts, 2021 - 2033
5.6.1.6. Fluoropolymers
5.6.1.6.1. Market Estimates and Forecasts, 2021 - 2033
5.6.1.7. Polytetrafluoroethylene (PTFE)
5.6.1.7.1. Market Estimates and Forecasts, 2021 - 2033
5.6.1.8. Fluorinated ethylene propylene (FEP)
5.6.1.8.1. Market Estimates and Forecasts, 2021 - 2033
5.6.1.9. Others
5.6.1.9.1. Market Estimates and Forecasts, 2021 - 2033
5.7. Others
5.7.1. Market Estimates and Forecasts, 2021 - 2033
5.7.1.1. Silicone
5.7.1.1.1. Market Estimates and Forecasts, 2021 - 2033
5.7.1.2. Polyolefins
5.7.1.2.1. Market Estimates and Forecasts, 2021 - 2033
5.7.1.3. Polyimide
5.7.1.3.1. Market Estimates and Forecasts, 2021 - 2033
5.7.1.4. Polyvinyl Chloride
5.7.1.4.1. Market Estimates and Forecasts, 2021 - 2033
5.7.1.5. Polycarbonates
5.7.1.5.1. Market Estimates and Forecasts, 2021 - 2033
5.7.1.6. Fluoropolymers
5.7.1.6.1. Market Estimates and Forecasts, 2021 - 2033
5.7.1.7. Polytetrafluoroethylene (PTFE)
5.7.1.7.1. Market Estimates and Forecasts, 2021 - 2033
5.7.1.8. Fluorinated ethylene propylene (FEP)
5.7.1.8.1. Market Estimates and Forecasts, 2021 - 2033
5.7.1.9. Others
5.7.1.9.1. Market Estimates and Forecasts, 2021 - 2033
Chapter 6. U.S. Medical Tubing Market - Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company Categorization
6.3. Company Market Share/Position Analysis, 2024
6.4. Company Heat Map Analysis
6.5. Strategy Mapping
6.5.1. Expansion
6.5.2. Mergers & Acquisition
6.5.3. Partnerships & Collaborations
6.5.4. New Process Launches
6.5.5. Research And Development
6.6. Company Profiles (Business Overview, Financial Performance, Product Benchmarking)
6.6.1. Hitachi Cable America Inc
6.6.2. NewAge Industries Inc.
6.6.3. Spectrum Plastics Group
6.6.4. Bentec Medical
6.6.5. Kent Elastomer Products
6.6.6. The Hygenic Company, LLC
6.6.7. Nordson Corporation